SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.642
EU - Europa 10.372
AS - Asia 7.158
SA - Sud America 105
AF - Africa 39
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 14
Totale 56.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.539
CN - Cina 3.546
IT - Italia 3.137
UA - Ucraina 2.394
SG - Singapore 1.529
TR - Turchia 1.443
DE - Germania 1.344
GB - Regno Unito 1.014
SE - Svezia 697
FI - Finlandia 564
PL - Polonia 487
ID - Indonesia 221
FR - Francia 217
VN - Vietnam 140
BE - Belgio 107
CA - Canada 79
IN - India 66
RU - Federazione Russa 60
NL - Olanda 56
BR - Brasile 52
CZ - Repubblica Ceca 48
ES - Italia 45
HK - Hong Kong 41
CH - Svizzera 31
LT - Lituania 25
IE - Irlanda 23
KR - Corea 23
CO - Colombia 21
AU - Australia 20
IR - Iran 17
RO - Romania 17
LK - Sri Lanka 16
EG - Egitto 14
PK - Pakistan 14
EU - Europa 12
HR - Croazia 12
MX - Messico 12
JP - Giappone 11
AL - Albania 10
HU - Ungheria 10
NZ - Nuova Zelanda 10
PT - Portogallo 10
TW - Taiwan 10
CL - Cile 9
IL - Israele 9
IQ - Iraq 9
TH - Thailandia 9
EC - Ecuador 8
GE - Georgia 8
GR - Grecia 8
NO - Norvegia 8
RS - Serbia 8
SA - Arabia Saudita 8
AT - Austria 7
BG - Bulgaria 7
DK - Danimarca 7
AR - Argentina 6
PH - Filippine 6
ZA - Sudafrica 6
MY - Malesia 5
MK - Macedonia 4
PE - Perù 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
YE - Yemen 4
BO - Bolivia 3
CU - Cuba 3
MD - Moldavia 3
MV - Maldive 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CM - Camerun 2
CY - Cipro 2
ET - Etiopia 2
GH - Ghana 2
JO - Giordania 2
KW - Kuwait 2
MA - Marocco 2
NI - Nicaragua 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EE - Estonia 1
GL - Groenlandia 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
Totale 56.352
Salva come PNG Salva come JPEG
Città #
Fairfield 5.337
Woodbridge 5.000
Houston 3.146
Jacksonville 2.703
Ashburn 2.647
Chandler 2.389
Ann Arbor 2.106
Seattle 2.089
Wilmington 1.864
Cambridge 1.776
Singapore 1.136
Santa Clara 1.132
Izmir 952
Nanjing 867
Princeton 751
Beijing 562
San Diego 477
Warsaw 471
Boardman 406
Milan 328
Ferrara 314
Shenyang 259
Shanghai 250
Nanchang 244
New York 230
Jakarta 210
Los Angeles 168
Falls Church 155
Hebei 147
Changsha 143
Jiaxing 143
Rome 141
Bremen 134
Redwood City 132
Tianjin 130
San Mateo 121
Mountain View 119
Dong Ket 118
London 112
Addison 107
Brussels 103
Jinan 97
Zhengzhou 83
Norwalk 82
Dearborn 80
Helsinki 65
Ningbo 64
Kunming 62
Naples 62
Washington 59
Bologna 54
Des Moines 53
Orange 51
Verona 51
Guangzhou 50
Philadelphia 48
Munich 47
Taizhou 45
Napoli 43
Indiana 38
Chicago 35
Tappahannock 35
Hong Kong 29
Turin 29
Auburn Hills 28
Florence 28
Hangzhou 27
Redmond 27
Ottawa 26
Changchun 24
Brno 23
Kilburn 23
Lanzhou 22
Padova 22
Bari 21
Frankfurt am Main 21
Toronto 21
Augusta 18
Palermo 18
Hounslow 17
Leawood 17
Olomouc 17
Catania 16
Torino 16
Genova 14
Pisa 14
San Francisco 14
Dublin 12
Wuhan 12
Yellow Springs 12
Cagliari 11
Haikou 11
Hefei 11
Monmouth Junction 11
Mumbai 11
Brescia 10
Hamburg 10
Lappeenranta 10
Montréal 10
Amsterdam 9
Totale 41.495
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.700
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 319
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 268
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 266
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 239
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 219
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 216
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 207
null 206
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 194
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 192
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 192
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 189
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 186
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 166
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 166
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 166
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 163
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 162
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion. 158
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 156
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 152
Heart failure with preserved ejection fraction: uncertainties and dilemmas 152
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 150
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 150
The role of Notch pathway in cardiovascular diseases. 150
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 148
Cardiac resynchronization therapy guided by multimodality cardiac imaging 148
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 147
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 147
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 147
Poor response to clopidogrel: current and future options for its management 146
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 145
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 145
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 145
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 142
Uric acid and coronary artery disease: An elusive link deserving further attention 142
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 142
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 141
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 139
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 138
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 138
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 137
2013 ESC guidelines on the management of stable coronary artery disease 137
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 137
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 134
Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 133
KRIT1 deficiency promotes aortic endothelial dysfunction 133
Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry 132
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 132
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 131
Reperfusion Damage - A Story of Success, Failure, and Hope 131
Cardiovascular complications of radiation therapy for thoracic malignancies: The role for non-invasive imaging for detection of cardiovascular disease 130
Individualized angiotensin-converting enzyme (ACE)-inhibitor therapy in stable coronary artery disease based on clinical and pharmacogenetic determinants: The PERindopril GENEtic (PERGENE) risk model 130
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 129
Can we improve myocardial protection during ischaemic injury? 129
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 128
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 127
Coronary artery disease: Use of ACE inhibitors in stable CAD - What is the truth? 127
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 127
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study 126
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 125
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 125
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 125
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 125
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 124
The in vitro effects of verbascoside on human platelet aggregation 123
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 123
Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using doppler measures of myocardial strain. 122
RESTING HEART RATE IN CARDIOVASCULAR DISEASE 121
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 121
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 121
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 120
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 120
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 120
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. 119
Not just numbers, but years of science: Putting the ACE inhibitor—ARB meta-analyses into context 119
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - Results from EUROPA 119
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis 119
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 119
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 118
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 118
Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems: Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure 118
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 118
Long-Term Effect of Perindopril on Coronary Atherosclerosis Progression (from the PERindopril's Prospective Effect on Coronary aTherosclerosis by Angiography and IntraVascular Ultrasound Evaluation [PERSPECTIVE] Study) 117
Is stunning an important component of preconditioning? 117
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 117
Current role of echocardiography in cardiac resynchronization therapy 117
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials 117
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 117
Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability. 116
Angiotensin-converting enzyme inhibition in cardiovascular disease evidence with perindopril 116
International cooperation in healthcare: Model of IRCCS Policlinico San Donato and Bambini Cardiopatici nel Mondo Association for congenital heart diseases 116
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 116
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 115
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease 115
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 115
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 115
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 115
Current views on anthracycline cardiotoxicity 115
Totale 15.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 265.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.193
Totale 269.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.683 0 0 0 0 857 1.426 1.121 1.276 1.024 1.199 488 292
2020/20218.376 681 744 515 930 363 913 316 1.061 254 1.119 996 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/20253.600 303 307 1.107 466 1.417 0 0 0 0 0 0 0
Totale 57.334